The Reporting of Harms in Randomized Controlled Trials of Hypertension Using the CONSORT Criteria for Harm Reporting

被引:22
|
作者
Bagul, Nitin Babulal [1 ]
Kirkham, Jamie J. [2 ]
机构
[1] Novartis Horsham Res Ctr, Horsham RH12 5AB, W Sussex, England
[2] Univ Liverpool, Dept Biostat, Liverpool L69 3GS, Merseyside, England
关键词
harm; adverse event; CONSORT; CONSORT extension; drug safety; ADVERSE EVENTS; QUALITY; STATEMENT; IMPROVE;
D O I
10.3109/10641963.2012.681724
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of this study was to assess the quality of reporting of harms in hypertension clinical trials identified from the Cochrane Database using the Consolidated Standards of Reporting Trials (CONSORT) extension for harms reporting. Forty-one hypertension trials were included in the study. On average trials reported less than half of the items recommended by the CONSORT extension for harms (mean 9.83 items; 95% confidence interval 8.06, 11.60). Trialists need to address the perceived shortcomings in measurement, analysis, and reporting of harms data so that the available trial data can be considered as a balanced and reliable source of evidence.
引用
收藏
页码:548 / 554
页数:7
相关论文
共 50 条
  • [31] CONSORT for reporting randomized controlled trials in journal and conference abstracts: Explanation and elaboration
    Hopewell, Sally
    Clarke, Mike
    Moher, David
    Wager, Elizabeth
    Middleton, Philippa
    Altman, Douglas G.
    Schulz, Kenneth F.
    PLOS MEDICINE, 2008, 5 (01) : 48 - 56
  • [32] Reporting quality of randomized controlled trials in otolaryngology: review of adherence to the CONSORT statement
    Huang, Yu Qing
    Traore, Katsiaryna
    Ibrahim, Badr
    Sewitch, Maida J.
    Nguyen, Lily H. P.
    JOURNAL OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2018, 47
  • [33] Guidelines for reporting randomized controlled trials in paediatric dentistry based on the CONSORT statement
    Jayaraman, Jayakumar
    INTERNATIONAL JOURNAL OF PAEDIATRIC DENTISTRY, 2020, 31 : 38 - 55
  • [34] Guidelines for reporting randomized controlled trials in paediatric dentistry based on the CONSORT statement
    Jayaraman, Jayakumar
    INTERNATIONAL JOURNAL OF PAEDIATRIC DENTISTRY, 2020, 31 : 38 - 55
  • [35] Methods and processes for development of a CONSORT extension for reporting pilot randomized controlled trials
    Thabane L.
    Hopewell S.
    Lancaster G.A.
    Bond C.M.
    Coleman C.L.
    Campbell M.J.
    Eldridge S.M.
    Pilot and Feasibility Studies, 2 (1)
  • [36] Quality of reporting of randomised controlled trials in chiropractic using the CONSORT checklist
    Karpouzis F.
    Bonello R.
    Pribicevic M.
    Kalamir A.
    Brown B.T.
    Chiropractic & Manual Therapies, 24 (1)
  • [37] Reporting of harm in randomized, controlled trials of nonpharmacologic treatment for rheumatic disease
    Ethgen, M
    Boutron, I
    Baron, G
    Giraudeau, B
    Sibilia, J
    Ravaud, P
    ANNALS OF INTERNAL MEDICINE, 2005, 143 (01) : 20 - 25
  • [38] Quality of Reporting of Harms in Randomized Controlled Trials: An Example Using Human Papillomavirus (HPV) Vaccines
    Smith, Leah M.
    Srighanthan, Jeevitha
    Poon, Karen K. Y.
    Levesque, Linda E.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 : S82 - S82
  • [39] Harms Reporting in Randomized Controlled Trials of Interventions Aimed at Modifying Microbiota RESPONSE
    Bafeta, Aida
    Koh, Mitsuki
    Riveros, Carolina
    Ravaud, Philippe
    ANNALS OF INTERNAL MEDICINE, 2019, 170 (02) : 143 - 144
  • [40] Reporting of Harms in Randomized Controlled Trials Published in Urology Journals: An Updated Analysis
    Anderson, Reece M.
    Pena, Andriana
    Magee, Trevor
    Perkins, Del
    Johnson, Bradley S.
    Breau, Rodney H.
    Vassar, Matt
    JOURNAL OF UROLOGY, 2024, 211 (01): : 48 - 54